Clinical Trial Update: Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Velcade (bortezomib) in adults with Philadelphia chromosome-positive leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: University of Bologna | Conditions: Leukemia | Phase 2 | Status: COMPLETED